The project will be conducted using three (3) research platforms:
Clinical Trial
The first research platform will be a clinical trial platform led by BNITM and CERMEL (WP 2).
Learn MoreMolecular Biology
The second platform on Molecular Biology is led by University Paris Descartes (France) and IRCB (Benin).
Learn MoreEntomology
The third platform is Entomology. It will be packed with a fair number of innovations and will research...
Learn MoreThe project will run in five (5) phases:
01
Study I
Pilot trial
02
Study II
Main trial
03
Study III
Pharmacokinetic analysis
04
Study IV
Transmission-blocking activity of AL+AP
05
Study V
Drug resistance selection